By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Following Thermo Fisher Scientific's announcement today that it will issue senior notes to fund in part its $3.5 billion acquisition of Phadia, ratings agency Fitch assigned an "A-" rating to the notes.

Thermo Fisher has not yet disclosed the terms of the notes or how much it expects to raise in the offering.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: transcript patterns in drug-resistant cancer cells, function of high-altitude adaption gene, and more.

Monitoring gene expression changes could help sniff out athletes using performance-enhancing drugs, New Scientist says.

The University of Southern California lodges a cross-complaint in its legal dispute with the University of California, San Diego, over a large Alzheimer's disease project.

In PLOS this week: gene fusion in premature ovarian failure, population patterns in the Franciscana dolphin, and more.